- Home
- BCBP vs CLLS Comparison
BCBP vs CLLS Comparison
Compare BCBP & CLLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCBP
- CLLS
- Stock Information
- Founded
- BCBP 2000
- CLLS 1999
- Country
- BCBP United States
- CLLS France
- Employees
- BCBP N/A
- CLLS N/A
- Industry
- BCBP Savings Institutions
- CLLS Biotechnology: Pharmaceutical Preparations
- Sector
- BCBP Finance
- CLLS Health Care
- Exchange
- BCBP Nasdaq
- CLLS Nasdaq
- Market Cap
- BCBP 143.5M
- CLLS 143.4M
- IPO Year
- BCBP N/A
- CLLS 2007
- Fundamental
- Price
- BCBP $8.67
- CLLS $1.83
- Analyst Decision
- BCBP Hold
- CLLS Buy
- Analyst Count
- BCBP 2
- CLLS 1
- Target Price
- BCBP $11.75
- CLLS $4.00
- AVG Volume (30 Days)
- BCBP 96.8K
- CLLS 128.3K
- Earning Date
- BCBP 07-29-2025
- CLLS 08-05-2025
- Dividend Yield
- BCBP 7.37%
- CLLS N/A
- EPS Growth
- BCBP N/A
- CLLS N/A
- EPS
- BCBP 0.15
- CLLS N/A
- Revenue
- BCBP $63,178,000.00
- CLLS $54,747,000.00
- Revenue This Year
- BCBP $22.28
- CLLS $48.52
- Revenue Next Year
- BCBP $10.55
- CLLS $5.17
- P/E Ratio
- BCBP $57.98
- CLLS N/A
- Revenue Growth
- BCBP N/A
- CLLS 351.26
- 52 Week Low
- BCBP $7.54
- CLLS $1.10
- 52 Week High
- BCBP $14.04
- CLLS $2.43
- Technical
- Relative Strength Index (RSI)
- BCBP 53.31
- CLLS 60.54
- Support Level
- BCBP $8.50
- CLLS $1.85
- Resistance Level
- BCBP $8.86
- CLLS $2.36
- Average True Range (ATR)
- BCBP 0.25
- CLLS 0.16
- MACD
- BCBP -0.03
- CLLS 0.04
- Stochastic Oscillator
- BCBP 38.27
- CLLS 48.06
About BCBP BCB Bancorp Inc. (NJ)
BCB Bancorp Inc is a bank holding company. The company offers loans, including commercial and multi-family real estate loans, home equity loans, construction loans, consumer loans, and commercial business loans; FDIC-insured deposit products, such as savings and club accounts, interest and non-interest bearing demand accounts, money market accounts, certificates of deposit and individual retirement accounts, and retail and commercial banking services, including wire transfers, money orders, safe deposit boxes, a night depository, debit cards, online banking, gift cards, fraud detection and automated teller services.
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.